Figure 3From: RRM1 single nucleotide polymorphism -37C→A correlates with progression-free survival in NSCLC patients after gemcitabine-based chemotherapyKaplan-Meier survival estimates based on RRM1 SNPs (A-C)for patients with NSCLC.Back to article page